Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) — Stock Score Summary

Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) has a MoatMap StockRank of 64/100 based on Quality (66/100), Value (43/100), and Momentum (39/100) factor scores. The current signal is HOLD. A traditional Chinese medicine manufacturer with localized domestic demand that does not align with our global macro themes or exhibit global scale economics.

Jiangsu Kanion Pharmaceutical Co., Ltd. researches, develops, and manufactures modern Traditional Chinese Medicine (TCM) formulations, focusing on gynecology, pediatrics, and cardiology. The company possesses a strong portfolio of proprietary, patent-protected TCM formulas with high clinical recognition in Chinese hospitals. It is a research-intensive pharmaceutical company recognized for its advanced automated TCM manufacturing processes.

Key Financial Metrics

Price$1.74
Market Cap$1.1B
P/E (TTM)23.30
P/E (Forward)11.33
Price/Book1.43
Return on Equity6.1%
Return on Invested Capital7.2%
Debt/Equity0.02
Gross Margin71.0%
Operating Margin11.3%
Revenue Growth-5.3%
Free Cash Flow$-7M

Jiangsu Kanion Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jiangsu Kanion Pharmaceutical Co.,Ltd.’s (600557.SS) StockRank?
MoatMap’s StockRank for Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) is 64/100, with a Hold signal. It is a composite of Quality (66), Value (43), and Momentum (39) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jiangsu Kanion Pharmaceutical Co.,Ltd. have an economic moat?
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jiangsu Kanion Pharmaceutical Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) is Hold, based on a StockRank of 64/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jiangsu Kanion Pharmaceutical Co.,Ltd. in?
Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600557.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock